2-Phenyl-2-(pyrrolidin-1-yl)-N-(1,3-thiazol-2-yl)acetamide

Catalog No.: 
ACQOLU907
CAS No.: 
866144-85-6
Molecular Formula: 
C15H17N3OS
Molecular Weight: 
287.39
2-Phenyl-2-(pyrrolidin-1-yl)-N-(1,3-thiazol-2-yl)acetamide structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
250mg90%$105.00InquiryInquiry
1g90%$325.00InquiryInquiry
5g90%$1609.00InquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name2-Phenyl-2-(pyrrolidin-1-yl)-N-(1,3-thiazol-2-yl)acetamide
IUPAC Name2-phenyl-2-(pyrrolidin-1-yl)-N-(thiazol-2-yl)acetamide
MDL No.MFCD03305934
Molecular FormulaC15H17N3OS
Molecular Weight287.39
SMILESO=C(NC1=NC=CS1)C(C2=CC=CC=C2)N3CCCC3
InChI KeyONFYFKKDTOPZKH-UHFFFAOYSA-N
Synonym2-PHENYL-2-(1-PYRROLIDINYL)-N-(1,3-THIAZOL-2-YL)ACETAMIDE;2-phenyl-2-(pyrrolidin-1-yl)-N-(1,3-thiazol-2-yl)acetamide;1-Pyrrolidineacetamide, α-phenyl-N-2-thiazolyl-
CAS No.866144-85-6

Synthetic Route by SureRoute

1. ACQOLU907 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACPLSU230 route compound structure diagram
    ACPLSU2306142-05-8In Stock
  2. Plus
  3. ACTVYF031 route compound structure diagram
    ACTVYF031100390-48-5In Stock
  4. Then
  5. ACQOLU907 route product structure diagram
    ACQOLU907866144-85-6
Inquiry

2. ACQOLU907 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACPLSU230 route compound structure diagram
    ACPLSU2306142-05-8In Stock
  4. Then
  5. ACQOLU907 route product structure diagram
    ACQOLU907866144-85-6
Inquiry

3. ACQOLU907 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACQOLU907 route product structure diagram
    ACQOLU907866144-85-6
Inquiry

Comments (0)